Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
J

French National Retrospective Cohort of Hairy-Cell Leukemias: Risk of Second Malignancies After 10 Years of Follow Up

By Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019) FEATURING Jerome Paillassa
By Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019) FEATURING Jerome Paillassa
19 views
October 18, 2019
0 Comments
Login to view comments. Click here to Login

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Related Content

AUTOPLAY
08:18
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Treatment Strategies for Hematocrit Control…

Feat. A. Zhou
09:27
ASH 2022 Conference Coverage

MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…

Feat. M. McMullin
16:25
Northwestern Medicine Oncology and Hematology

Diagnosis and Goals of Therapy in PV

Feat. B. Stein
10:49
Monia Marchetti

Using Cytoreductive Therapy to Prevent Cardiovascular Events in Pati…

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter
31:02
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024

Detangling New Approaches to Hairy Cell Leukemia - A Comb or a Brush?

Feat. D. Hermel
12:27
MyCancerHaven

Experts Discuss the Basics of Diagnosis and Treatment of Hairy Cell …

Feat. R. Vij, L. Andritsos
12:47
2019 Scripps MD Anderson's Oncology Update

Lymphoma Practicing Changing ASCO19 Studies: Novel Agents Prior to R…

Feat. A. Saven
25:01
Indy Hematology Review

Review of Emerging Therapies and Top Trials in Hematologic Malignanc…

Feat. R. Birhiray
09:31
KU Hematology & Medical Oncology Review 2019

KU ASCO 2019 Hairy Cell Leukemia Highlights - Moxetumomab Pasudotox …

Feat. A. Yacoub
22:37
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "The Best of Acute Leukemia and MDS - Highlig…

Feat. T. Badar
21:05
Louisville Hematology Highlights

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Feat. R. Gale
12:47
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "Experts Discuss Key Abstracts in CLL"

Feat. S. O'Brien, C. Coombs
17:05
Cleveland Clinic Taussig Cancer Institute

Frontline CLL Learnings From Phase 3 RESONATE-2, iLLUMINATE, and E19…

Feat. A. Winter
04:16
Luke Fletcher

Efficacy and Safety of Asciminib in Ph+ CML

50:34
Scripps MD Anderson Cancer Center

The Cure of Leukemias in the Next Decade: An Optimist’s View

Feat. H. Kantarjian
06:00
2024 Clinical Case Studies

Clinical Case Review: A Not-So-Sweet Case of Vulvar Ulceration

Feat. A. Geisler
06:53
UC Irvine Health

Fixed-Duration Treatment in CLL: Current Considerations

Feat. E. Brem
20:18
XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Will Immune Therapy Replace Transplant in Hematologic Malignancies?

Feat. R. Gale
24:33
Indy Hematology Review

Therapeutic Options in CLL in 2023: Choosing the Initial Therapy Wis…

Feat. J. Woyach